Connect with us

International Circuit

How MediSieve Plans To Treat Blood-Borne Diseases Including Malaria And Leukaemia Using Magnetic Filtration

London-based medical device company Medisieve has developed a technology with the potential to revolutionise the treatment of blood-borne diseases such as sepsis, malaria and leukaemia.

Known as Magnetic Blood Filtration, it’s a method that consists of removing various components from the blood, which could be the likes of specific cell populations, pathogens, toxins, or cytokines.

It was developed by Dr George Frodsham, CEO and founder of MediSieve.

He told NS Medical Devices: “The potential impact in all these diseases is significant – these are some of mankind’s most deadly diseases and they cause huge suffering.

“Malaria, for example, kills 450 million children every year, there are six million patients worldwide who are hospitalised with severe disease and could benefit from magnetic blood filtration.

“Sepsis kills 45,000 every year in the UK – about the same as the average capacity of a premier league football stadium.

“Leukaemia is one of the most common cancers and biggest killers of children in the developed world.”

The device has not been trialled in humans, so is not currently available for treatments. Once validated in clinical trials, it will be used exclusively in hospitals. – NS Medical Devices

Copyright © 2024 Medical Buyer

error: Content is protected !!